Article | April 14, 2022

The Call To Action On DCTs: No Going Back

Source: Curebase
Actionable Insights For The Pharmaceutical And Biotech Industry

We’ve all lived through more than two years we never imagined.  A good friend of mine likens it to a prolonged episode of Black Mirror.  

I remember sitting at this desk, in this chair, in March 2020, one month into a new job to drive the adoption of Decentralized Trials at scale, and wondering what the heck was coming next.  The news cycle was speeding up and we were all seeking information. The world was slowing down in many ways, like office closures, travel bans, and supply chain crises.  

Clinical trials were in a free fall.  What the heck was coming next?

To learn more about Curebase, visit their Clinical Leader page.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Clinical Leader